Newsletter - Banner

Breadcrumb

Asset Publisher

angle-left 4th Annual MeDiC Research Day (March 29, 2019)

Where: At the Research Institute of the McGill University Health Centre (RI-MUHC) Glen Site, Drs Sylvia & Richard Cruess Amphitheatre and Atrium, E.S1.1129, 1001 Decarie Boulevard, Montreal, Quebec H4A 3J1

When: Friday, March 29, 2019

Register by: March 15, 2019
Submit abstract by: March 1, 2019
Register and submit abstract today at: http://tinyurl.com/y2jq5bdl

Keynote Speaker 2019
The MeDiC Research Program is pleased to announce that Dr. Paul Anderson will be giving the key note presentation at this year’s annual research day.

Inception Sciences – Bridging the Translation Gap
Paul Anderson, Ph.D., CSO of Inception IBD and Montreal Site Head

Dr. Paul C. Anderson, Ph.D. Inception Sciences


Career & Education
Dr. Paul C. Anderson, Ph.D. is the site-head for Inception Sciences Montreal and CSO, Inception IBD. He was a Consultant for the National Institutes of Health (NIH) Blueprint Neurotherapeutics Network (BPN). Dr. Anderson has been Chief Scientific Officer of Inception Sciences, Inc. since November 2015. He served as Vice President of Chemistry at Ra Pharmaceuticals, Inc. since March 2011. Dr. Anderson served as Vice President of Medicinal Chemistry at Syndexa Pharmaceuticals Corporation since November 2008. He spent more than 20 years at Boehringer Ingelheim where he and his team introduced several anti-viral drugs into pre-clinical and clinical development, including the first hepatitis C virus protease inhibitor to be tested in humans. Dr. Anderson is a synthetic organic chemist by training with more than 30 years of experience in pharmaceutical research and development. He began his career in the pharmaceutical industry at Merck Frost Canada Inc. He has served on the Board of Directors of the Canadian Society for Chemistry and the Montréal Joint Center for Structural Biology and on the Editorial Advisory Board of the Canadian Journal of Chemistry. Dr. Anderson has 40 scientific publications and patents in the areas of synthetic and medicinal chemistry and anti-viral research. He served as a Member of Scientific Advisory Board at InMed Pharmaceuticals Inc. since March 2015 until November 14, 2017. Dr. Anderson received his Bachelor of Science (Honors) degree in chemistry from the University of Western Ontario in London, Ontario and his Ph.D. in synthetic organic chemistry at the University of Alberta in Edmonton, Alberta. He carried out postdoctoral research in bio-organic chemistry at Cambridge University in the United Kingdom.

About Inception
Inception Sciences is a drug discovery engine co-founded with Versant Ventures in 2011, with operating sites in the US (San Diego) and Canada (Vancouver and Montreal). Inception Sciences creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. (from http://www.inceptionsci.com/about/)

Program Schedule
9:00 REGISTRATION
9:15 OPENING REMARKS
9:30 ORAL PRESENTATIONS I
10:15 COFFEE BREAK
10:45 ORAL PRESENTATIONS II
11:45 BLITZ PRESENTATIONS
12:15 LUNCH
13:15 KEYNOTE LECTURE: Inception Sciences – Bridging the Translation Gap by Dr. Paul Anderson
14:15 POSTER SESSION
16:00 AWARD CEREMONY
16:20 COCKTAIL

Click here to view the poster for this event

MeDiC Research Day 2018
MeDiC Research Day 2018